About Nicotine Patch
A nicotine patch is a smoking cessation product that helps the smokers to slowly reduce their addiction to nicotine. The patch is worn on the skin. It releases stream of nicotine into the blood through the skin. This helps reduce the physical withdrawal symptoms that occur during the initial period of quitting smoking. It provides a continual level of nicotine throughout the day. The patches help the human body battle the strong urges for nicotine after reducing the number of cigarettes smoked. Patches are available in various dosages and they can be applied according to the level of addiction.
TechNavio's analysts forecast the Global Nicotine Patch market will grow at a CAGR of 18.05 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Nicotine Patch market for the period 2014-2018. To calculate market size, the report considers revenue generated through the sales of nicotine patches. These products are one form of nicotine replacement therapy. The other forms are nicotine lozenges and gum.
TechNavio's report, the Global Nicotine Patch Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Western Europe, the APAC region, Eastern and Central Europe, South America, and the ROW; it also covers the Global Nicotine Patch market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• North America
• Western Europe
• APAC
• Eastern and Central Europe
• South America
• ROW
Key Vendors
• GlaxoSmithKline plc
• Johnson and Johnson
• Novartis AG
• The Harvard Drug Group LLC
Other Prominent Vendors
• Target Corp.
• Walgreen Co.
• Wal-Mart Stores Inc.
Key Market Driver
• Increased Awareness of Smoking Health Hazard
• For a full, detailed list, view our report.
Key Market Challenge
• Side-effects of Nicotine Patch
• For a full, detailed list, view our report.
Key Market Trend
• Emergence of Zero Nicotine Patch
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. World Cigarette Statistics: Per Capita Consumption Per Year
08. NRT Products Price Comparison
09. Geographical Segmentation
09.1 Global Nicotine Patch Market by Geographical Segmentation 2013-2018
09.2 Nicotine Patch Market in North America
09.2.1 Market Size and Forecast
09.3 Nicotine Patch Market in Western Europe
09.3.1 Market Size and Forecast
09.4 Nicotine Patch Market in the APAC Region
09.4.1 Market Size and Forecast
09.5 Nicotine Patch Market in Eastern and Central Europe
09.5.1 Market Size and Forecast
09.6 Nicotine Patch Market in South America
09.6.1 Market Size and Forecast
09.7 Nicotine Patch Market in the ROW
09.7.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 GlaxoSmithKline plc
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Business Segmentation by Revenue 2012 and 2013
18.1.4 Sales by Geography
18.1.5 Key Information
18.1.6 SWOT Analysis
18.2 Johnson and Johnson
18.2.1 Business Overview
18.2.2 Business Segmentation
18.2.3 Key Information
18.2.4 SWOT Analysis
18.3 Novartis AG
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 The Harvard Drug Group LLC
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis
19. Other Prominent Vendors
19.1 Target Corp.
19.2 Walgreen Co.
19.3 Wal-Mart Stores Inc.
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Residential Robotic Vacuum Cleaners
Exhibit 3: Global Nicotine Patch Market 2013-2018 (US$ million)
Exhibit 4: World Cigarette Statistics: Per Capita Consumption Per Year
Exhibit 5: NRT Products Price Comparison
Exhibit 6: Global Nicotine Patch Market by Geographical Segmentation 2013
Exhibit 7: Global Nicotine Patch Market by Geographical Segmentation 2018
Exhibit 8: Global Nicotine Patch Market by Geographical Segmentation 2013-2018 (US$ million)
Exhibit 9: Global Nicotine Patch Market by Geographical Segmentation 2013-2018
Exhibit 10: Nicotine Patch Market in North America 2013-2018 (US$ million)
Exhibit 11: Nicotine Patch Market in Western Europe 2013-2018 (US$ million)
Exhibit 12: Nicotine Patch Market in APAC 2013-2018 (US$ million)
Exhibit 13: Nicotine Patch Market in Eastern and Central Europe 2013-2018 (US$ million)
Exhibit 14: Nicotine Patch Market in South America 2013-2018 (US$ million)
Exhibit 15: Nicotine Patch Market in the ROW 2013-2018 (US$ million)
Exhibit 16: Comparison of CAGR (Revenue) among Key Geographies in the Global Nicotine Patch Market 2014-2018
Exhibit 17: Global Nicotine Patch Market by Geography 2013-2018 (US$ million)
Exhibit 18: Global Nicotine Patch Market by Geography 2013-2018 (percentage)
Exhibit 19: Different Pack Size and Price of Habitrol Nicotine Transdermal Patch by Novartis Consumer Health Inc.
Exhibit 20: GlaxoSmithKline Plc: Business Segmentation 2013
Exhibit 21: GlaxoSmithKline Plc: Business Segmentation by Revenue 2012 and 2013 (in US$ billion)
Exhibit 22: GlaxoSmithKline Plc: Sales by Geography 2013
Exhibit 23: Johnson and Johnson: Business Segmentation 2013
Exhibit 24: Novartis AG: Business Segmentation 2013
Exhibit 25: The Harvard Drug Group LLC: Business Segmentation 2013
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
